CYS: Alumni Day
CanCell Young Scientists has the pleasure to invite you to Alumni Day, an event where you can come and find out about opportunities outside of academia. With only 3% of PhDs that obtain professor positions, it is high time to discuss attractive possibilities away from this Institute and the University. We have invited a selection of scientists who will be able to answer your questions concerning how they got to where they are, with a focus on the transition process.
13:00-13:45 Lars Christian Lassen
14:00-15:00 Q & A with selected participants
Lars Christian Lassen did his PhD in medical research at the University of Copenhagen, from which he also holds an MD. He worked as the medical director at Novo Nordisk, before transitioning into Human Resources as senior vice president. He has developed leadership programmes at IMD Business School and Harvard Business School. He is now the leader of Mobilize Strategy Consulting, a company that helps individuals and companies mobilise and unfold their true strategic potential.
Ingrid Roxrud did her PhD in the group of Harald Stenmark and started at the Norwegian Research council in 2014. She was then the first Norwegian sent to Brussels as a national expert where she lived for 2 years. She is now back in Norway and continues to work at the Norwegian Research Council.
Iwona Grad is originally from Poland where she did her PhD. After a postdoctoral period in Geneva, Switzerland, she joined the group of Ola Myklebost at the Department of Tumour Biology. In 2019 she joined Thermo Fischer as a staff scientist. Ask her about finding a job outside of academia without speaking Norwegian!
Anne-Mari Håkelien did her PhD at the University of Oslo. She did her first postdoc at the Institute for Basic Medical Sciences during which she spent one year at Columbia University Medical Center. She then joined the Institute for Cancer Research for her second postdoc where she worked in the project group of Leonardo Meza-Zepeda. Since, she has worked at the Norwegian Directorate of Health and is currently a senior adviser at The Norwegian Medicines Agency.
Christian Bindesbøll did his PhD in the group of Hilde Nebb at the University of Oslo. During this time he spent one year at the University of Southern Denmark. He then joined the group of Anne Simonsen as a postdoc, and started as a medical science liaison at Novartis in 2018. In January this year he started working at Roche as a country medical manager within oncology.
Erik Torheim did his PhD in the group of Kjetil Tasken at the University of Oslo. He then did a short postdoc at Institut Pasteur in Paris, and then created the company Torheim Pharmaceuticals where he worked as the CEO. He then worked at Apokus as well as Moonwalk Innovation, Sumandir, Depict, Life Science Team and Inkubator Romsås.
Raimonda Viburiene did her PhD in molecular microbiology in the group of Michael Koomey at the University of Oslo. She has worked as a scientist, an office manager, a consultant, national studies coordinator as well as an assisting teacher in natural sciences and mathematics. She now works as a scientific officer at Coalition for Epidemic Preparedness Innovations (CEPI).
Adam Robertson did his PhD at the University of North Carolina Chapel Hill. He did his postdoc at Oslo University Hospital and started there as a group leader in 2014. He became chief scientific officer at Regenics in 2019 and also works as Hemispherian as a chief scientific officer.
Hilde Abrahamsen Enserink did her PhD in the group of Kjetil Tasken. She then went on to do a postdoc as UCSD, and came back to Norway in the group of Harald Stenmark. She started working at AbbVie in 2012 where she was a medical advisor, the associated head of medical affairs within hematology/oncology, and the medical manager oncology/hematology. She recently started working as the oncology medical country lead at MSD.